Corbus Pharmaceuticals Holdings
Stock Forecast, Prediction & Price Target
Corbus Pharmaceuticals Holdings (CRBP) stock Price Target by analysts
$47.5
Potential upside: 420.26%
Corbus Pharmaceuticals Holdings price prediction
What is Corbus Pharmaceuticals Holdings stock analysts` prediction?
Corbus Pharmaceuticals Holdings stock forecast: Based on 2 Wall Street analysts` predicted price targets for Corbus Pharmaceuticals Holdings in the last 3 months, the avarage price target is $47.5, with a high forecast of $NaN. The average price target represents a 420.26% change from the last price of $9.13.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Corbus Pharmaceuticals Holdings stock Price Target by analysts
Full breakdown of analysts given Corbus Pharmaceuticals Holdings price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Biren Amin Piper Sandler | 0% 0/1 | 10 months ago | $35 283.35% upside | $17.82 | StreetInsider | Previous targets (0) |
Jeff Jones Oppenheimer | 0% 0/3 | 11 months ago | $60 557.17% upside | $18.41 | StreetInsider | Previous targets (2) |
Kalpit Patel B.Riley Financial | 0% 0/1 | about 1 year ago | $40 338.11% upside | $19.51 | StreetInsider | Previous targets (0) |
Graig Suvannavejh Mizuho Securities | 0% 0/1 | about 1 year ago | $74 710.51% upside | $51.58 | StreetInsider | Previous targets (0) |
Jeff Jones Oppenheimer | 0% 0/3 | about 1 year ago | $88 863.85% upside | $48.3 | StreetInsider | Previous targets (2) |
Andres Maldonado H.C. Wainwright | 0% 0/1 | about 1 year ago | $80 776.23% upside | $58 | TheFly | Previous targets (0) |
Brian Abrahams RBC Capital | 0% 0/2 | over 1 year ago | $82 798.13% upside | $43.87 | StreetInsider | Previous targets (1) |
Jeff Jones Oppenheimer | 0% 0/3 | over 1 year ago | $80 776.23% upside | $42.8 | StreetInsider | Previous targets (2) |
Brian Abrahams RBC Capital | 0% 0/2 | over 1 year ago | $77 743.37% upside | $45 | StreetInsider | Previous targets (1) |
Maury Raycroft Jefferies | 0% 0/1 | over 1 year ago | $46 403.83% upside | $33.58 | StreetInsider | Previous targets (0) |
Corbus Pharmaceuticals Holdings Financial Estimates
Corbus Pharmaceuticals Holdings Revenue Estimates
Corbus Pharmaceuticals Holdings EBITDA Estimates
Corbus Pharmaceuticals Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $881.70K N/A | $0 -100% | $0 0% | Avg: $10M Low: $10M High: $10M avg. 0% | Avg: $25M Low: $25M High: $25M avg. 150% | Avg: $25M Low: $25M High: $25M avg. 0% | Avg: $50M Low: $50M High: $50M avg. 100% |
Net Income
% change YoY
| $-45.55M N/A | $-55.83M -22.56% | $-44.60M 20.11% | Avg: $-20.42M Low: $-25.51M High: $-15.53M avg. 54.20% | Avg: $-20.74M Low: $-20.74M High: $-20.74M avg. -1.55% | Avg: $-23.16M Low: $-23.16M High: $-23.16M avg. -11.68% | Avg: $-25.41M Low: $-25.41M High: $-25.41M avg. -9.71% |
EBITDA
% change YoY
| $-56.26M N/A | $-29.50M 47.56% | $-44.43M -50.60% | Avg: $-1.99M Low: $-1.99M High: $-1.99M avg. 95.49% | Avg: $-4.99M Low: $-4.99M High: $-4.99M avg. -150.00% | Avg: $-4.99M Low: $-4.99M High: $-4.99M avg. 0% | Avg: $-9.99M Low: $-9.99M High: $-9.99M avg. -100.00% |
EPS
% change YoY
| -$11.11 N/A | -$13.39 -20.52% | -$10.31 23.00% | Avg: -$4.72 Low: -$5.9 High: -$3.59 avg. 54.21% | Avg: -$4.79 Low: -$4.79 High: -$4.79 avg. -1.55% | Avg: -$5.35 Low: -$5.35 High: -$5.35 avg. -11.68% | Avg: -$5.87 Low: -$5.87 High: -$5.87 avg. -9.71% |
Operating Expenses
% change YoY
| $56.87M N/A | $34.83M -38.74% | $13.90M -60.07% | Avg: $66.10M Low: $66.10M High: $66.10M avg. 375.26% | Avg: $165.26M Low: $165.26M High: $165.26M avg. 149.99% | Avg: $165.26M Low: $165.26M High: $165.26M avg. 0% | Avg: $330.53M Low: $330.53M High: $330.53M avg. 100.00% |
FAQ
What is Corbus Pharmaceuticals Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 7.81% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -25.51M, average is -20.42M and high is -15.53M.
What is Corbus Pharmaceuticals Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 62.5% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $10M, average is $10M and high is $10M.
What is Corbus Pharmaceuticals Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 7.81% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$5.9, average is -$4.72 and high is $-3.59.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Corbus Pharmaceuticals Holdings stock. The most successful analyst is Biren Amin.